REG - BB Healthcare Trust - Directorate Change

PerpetualAnnouncement

05/07/2021 08:05

RNS Number : 0657E
  
BB Healthcare Trust PLC
  
05 July 2021
  
 

5 July 2021
BB Healthcare Trust plc (the "Company")
LEI: 213800HQ3J3H9YF2UI82
Director Appointment
The Board of BB Healthcare Trust plc is pleased to announce the appointment of Kate Bolsover as a Non-Executive Director of the Company with immediate effect. Ms Bolsover will also be appointed as a member of the Audit and Risk Committee and the Management Engagement Committee following her appointment to the Board.
 
Kate has extensive experience in fund management with marketing, communications, and investment expertise. She previously worked for Cazenove Group plc and J.P. Morgan Cazenove between 1995 and 2005 where she was Managing Director of the mutual fund business, and latterly Director of Corporate Communications. Kate was also previously a Non-Executive Director of JP Morgan American Investment Trust plc until 2016, Chairman and Trustee of Tomorrow's People until 2017, Senior Independent Director of Montanaro UK Smaller Companies Investment Trust Plc until 2019 and Chairman of Invesco Enhanced Income Limited ("IPE") until its merger with Invesco Bond Income Plus ("BIPS") (previously City Merchant High Yield Trust Limited ("CMHY")) in May 2021 at which time she joined the BIPS board as Senior Independent Director.
 
Kate is currently Chairman of Fidelity Asian Values Investment Trust plc, Non-Executive Director of TR Property Investment Trust plc and Senior Independent Director of Invesco Bond Income Plus Limited. She is also Non-Executive Director of Baillie Gifford & Co Limited (which acts as the Authorised Corporate Director and Alternative Investment Fund Manager for a number of Baillie Gifford managed funds).
 
Randeep Grewal, Chairman, commented: 
"I am delighted to welcome Kate to the Board as a Non-Executive Director. Kate brings a wealth of experience particularly in investment trusts and at board level and we are confident that she will make a valuable contribution to the Company."
 
Other than as set out above there are no items requiring disclosure under paragraph 9.6.13 of the FCA Listing Rules. However, to ensure full transparency, it is noted that IPE merged with CMHY by way of a shareholder approved scheme of reconstruction. Upon the scheme of reconstruction becoming effective, the name of CMHY changed to BIPS.
 
Enquiries:                                             
Company Secretary                               020 4513 9260
PraxisIFM Fund Services (UK) Limited
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
BOAMZGGNVZZGMZM